{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:32:57Z","timestamp":1790760777653,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,5,7]],"date-time":"2004-05-07T00:00:00Z","timestamp":1083888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,5,7]],"date-time":"2004-05-07T00:00:00Z","timestamp":1083888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/bcr798","type":"journal-article","created":{"date-parts":[[2004,5,8]],"date-time":"2004-05-08T06:22:20Z","timestamp":1083997340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study"],"prefix":"10.1186","volume":"6","author":[{"given":"Chi-Chen","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Kou","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey L","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tritchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Yaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman F","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,5,7]]},"reference":[{"key":"800_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"The Endogenous Hormones and Breast Cancer Collaborative Group","year":"2002","unstructured":"The Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002, 94: 606-616. 10.1093\/jnci\/94.8.606.","journal-title":"J Natl Cancer Inst"},{"key":"800_CR2","first-page":"414","volume":"270","author":"T Shimada","year":"1994","unstructured":"Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 1994, 270: 414-423.","journal-title":"J Pharmacol Exp Ther"},{"key":"800_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1021\/tx970217f","volume":"11","author":"H Yamazaki","year":"1998","unstructured":"Yamazaki H, Shaw PM, Guengerich FP, Shimada T: Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol. 1998, 11: 659-665. 10.1021\/tx970217f.","journal-title":"Chem Res Toxicol"},{"key":"800_CR4","first-page":"3914","volume":"84","author":"X Xu","year":"1999","unstructured":"Xu X, Duncan AM, Merz-Demlow BE, Phipps WR, Kurzer MS: Menstrual cycle effects on urinary estrogen metabolites. J Clin Endocrinol Metab. 1999, 84: 3914-3918. 10.1210\/jc.84.11.3914.","journal-title":"J Clin Endocrinol Metab"},{"key":"800_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev.pa.36.040196.001223","volume":"36","author":"JD Yager","year":"1996","unstructured":"Yager JD, Liehr JG: Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol. 1996, 36: 203-232. 10.1146\/annurev.pa.36.040196.001223.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"800_CR6","first-page":"131","volume":"9","author":"I Tantcheva-Poor","year":"1999","unstructured":"Tantcheva-Poor I, Zaigler M, Rietbrock S, Fuhr U: Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics. 1999, 9: 131-144.","journal-title":"Pharmacogenetics"},{"key":"800_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/clpt.1991.176","volume":"50","author":"W Kalow","year":"1991","unstructured":"Kalow W, Tang BK: Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther. 1991, 50: 508-519.","journal-title":"Clin Pharmacol Ther"},{"key":"800_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a022352","volume":"125","author":"M Nakajima","year":"1999","unstructured":"Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T: Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem (Tokyo). 1999, 125: 803-808.","journal-title":"J Biochem (Tokyo)"},{"key":"800_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1749-6632.1990.tb34303.x","volume":"595","author":"JJ Michnovicz","year":"1990","unstructured":"Michnovicz JJ, Bradlow HL: Dietary and pharmacological control of estradiol metabolism in humans. Ann N Y Acad Sci. 1990, 595: 291-299.","journal-title":"Ann N Y Acad Sci"},{"key":"800_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/clpt.1993.63","volume":"53","author":"W Kalow","year":"1993","unstructured":"Kalow W, Tang BK: The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther. 1993, 53: 503-514.","journal-title":"Clin Pharmacol Ther"},{"key":"800_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00008571-199406000-00002","volume":"4","author":"BK Tang","year":"1994","unstructured":"Tang BK, Zhou Y, Kadar D, Kalow W: Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements. Pharmacogenetics. 1994, 4: 117-124.","journal-title":"Pharmacogenetics"},{"key":"800_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1046\/j.1365-2125.1999.00918.x","volume":"47","author":"A Nordmark","year":"1999","unstructured":"Nordmark A, Lundgren S, Cnattingius S, Rane A: Dietary caffeine as a probe agent for assessment of cytochrome P4501A2 activity in random urine samples. Br J Clin Pharmacol. 1999, 47: 397-402. 10.1046\/j.1365-2125.1999.00918.x.","journal-title":"Br J Clin Pharmacol"},{"key":"800_CR13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/sj.bjc.6600537","volume":"87","author":"NF Boyd","year":"2002","unstructured":"Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S: The association of breast mitogens with mammographic densities. Br J Cancer. 2002, 87: 876-882. 10.1038\/sj.bjc.6600537.","journal-title":"Br J Cancer"},{"key":"800_CR14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-8223(21)00707-0","volume":"92","author":"G Block","year":"1992","unstructured":"Block G, Thompson FE, Hartman AM, Larkin FA, Guire KE: Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc. 1992, 92: 686-693.","journal-title":"J Am Diet Assoc"},{"key":"800_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/clpt.1991.82","volume":"49","author":"BK Tang","year":"1991","unstructured":"Tang BK, Kadar D, Qian L, Iriah J, Yip J, Kalow W: Caffeine as a metabolic probe: validation of its use for acetylator phenotyping. Clin Pharmacol Ther. 1991, 49: 648-657.","journal-title":"Clin Pharmacol Ther"},{"key":"800_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00008571-200004000-00001","volume":"10","author":"DS Streetman","year":"2000","unstructured":"Streetman DS, Bertino JS, Nafziger AN: Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics. 2000, 10: 187-216. 10.1097\/00008571-200004000-00001.","journal-title":"Pharmacogenetics"},{"key":"800_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0009-9236(98)90105-9","volume":"63","author":"AD Kashuba","year":"1998","unstructured":"Kashuba AD, Bertino JS, Kearns GL, Leeder JS, James AW, Gotschall R, Nafziger AN: Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Clin Pharmacol Ther. 1998, 63: 540-551.","journal-title":"Clin Pharmacol Ther"},{"key":"800_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/clpt.1993.63","volume":"53","author":"W Kalow","year":"1993","unstructured":"Kalow W, Tang BK: The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther. 1993, 53: 503-514.","journal-title":"Clin Pharmacol Ther"},{"key":"800_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/sj.bjc.6600537","volume":"87","author":"NF Boyd","year":"2002","unstructured":"Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S: The association of breast mitogens with mammographic densities. Br J Cancer. 2002, 87: 876-882. 10.1038\/sj.bjc.6600537.","journal-title":"Br J Cancer"},{"key":"800_CR20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jnci\/75.5.823","volume":"75","author":"MS Langley","year":"1985","unstructured":"Langley MS, Hammond GL, Bardsley A, Sellwood RA, Anderson DC: Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases. J Natl Cancer Inst. 1985, 75: 823-829.","journal-title":"J Natl Cancer Inst"},{"key":"800_CR21","volume-title":"Manual of Laboratory Operations, Lipid Research Clinics Program \u2013 1. Lipid and Lipoprotein Analysis","author":"National Heart Lung and Blood Institute","year":"1982","unstructured":"National Heart Lung and Blood Institute: Manual of Laboratory Operations, Lipid Research Clinics Program \u2013 1. Lipid and Lipoprotein Analysis. 1982, Bethesda: National Heart, Lung and Blood Institute"},{"key":"800_CR22","volume-title":"SAS\/STAT User's Guide, version 6","author":"SAS Institute Inc","year":"1989","unstructured":"SAS Institute Inc: SAS\/STAT User's Guide, version 6. 1989, Cary, NC: SAS Institute Inc"},{"key":"800_CR23","volume-title":"Multivariable Analysis: a Practical Guide for Clinicians","author":"MH Katz","year":"1999","unstructured":"Katz MH: Multivariable Analysis: a Practical Guide for Clinicians. 1999, Cambridge: Cambridge University Press"},{"key":"800_CR24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jnci\/75.5.823","volume":"75","author":"MS Langley","year":"1985","unstructured":"Langley MS, Hammond GL, Bardsley A, Sellwood RA, Anderson DC: Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases. J Natl Cancer Inst. 1985, 75: 823-829.","journal-title":"J Natl Cancer Inst"},{"key":"800_CR25","first-page":"413","volume":"3","author":"M Nakajima","year":"1994","unstructured":"Nakajima M, Yokoi T, Mizutani M, Shin S, Kadlubar FF, Kamataki T: Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol Biomarkers Prev. 1994, 3: 413-421.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"800_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s002280050394","volume":"53","author":"D Schrenk","year":"1998","unstructured":"Schrenk D, Brockmeier D, Morike K, Bock KW, Eichelbaum M: A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. Eur J Clin Pharmacol. 1998, 53: 361-367. 10.1007\/s002280050394.","journal-title":"Eur J Clin Pharmacol"},{"key":"800_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/00007691-199610000-00011","volume":"18","author":"A Bartoli","year":"1996","unstructured":"Bartoli A, Xiaodong S, Gatti G, Cipolla G, Marchiselli R, Perucca E: The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: a comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate. Ther Drug Monit. 1996, 18: 586-591. 10.1097\/00007691-199610000-00011.","journal-title":"Ther Drug Monit"},{"key":"800_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00008571-200208000-00008","volume":"12","author":"BB Rasmussen","year":"2002","unstructured":"Rasmussen BB, Brix TH, Kyvik KO, Brosen K: The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics. 2002, 12: 473-478. 10.1097\/00008571-200208000-00008.","journal-title":"Pharmacogenetics"},{"key":"800_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00898.x","volume":"47","author":"C Sachse","year":"1999","unstructured":"Sachse C, Brockmoller J, Bauer S, Roots I: Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol. 1999, 47: 445-449. 10.1046\/j.1365-2125.1999.00898.x.","journal-title":"Br J Clin Pharmacol"},{"key":"800_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1677\/joe.0.1530251","volume":"153","author":"Y Hong","year":"1997","unstructured":"Hong Y, Brismar K, Hall K, Pedersen NL, de Faire U: Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: results from middle-aged and elderly monozygotic twins. J Endocrinol. 1997, 153: 251-257.","journal-title":"J Endocrinol"},{"key":"800_CR31","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/gepi.1013","volume":"20","author":"JE Olson","year":"2001","unstructured":"Olson JE, Atwood LD, Grabrick DM, Vachon CM, Sellers TA: Evidence for a major gene influence on abdominal fat distribution: the Minnesota Breast Cancer Study. Genet Epidemiol. 2001, 20: 458-478. 10.1002\/gepi.1013.","journal-title":"Genet Epidemiol"},{"key":"800_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1023\/A:1005831013718","volume":"47","author":"ME Del Giudice","year":"1998","unstructured":"Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ: Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat. 1998, 47: 111-120. 10.1023\/A:1005831013718.","journal-title":"Breast Cancer Res Treat"},{"key":"800_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.20.1.42","volume":"20","author":"PJ Goodwin","year":"2002","unstructured":"Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N: Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002, 20: 42-51. 10.1200\/JCO.20.1.42.","journal-title":"J Clin Oncol"},{"key":"800_CR34","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","volume":"351","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE, Willet WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998, 351: 1393-1396. 10.1016\/S0140-6736(97)10384-1.","journal-title":"Lancet"},{"key":"800_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1067\/mcp.2002.121373","volume":"71","author":"G Jurgens","year":"2002","unstructured":"Jurgens G, Lange KH, Reuther LO, Rasmussen BB, Brosen K, Christensen HR: Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men. Clin Pharmacol Ther. 2002, 71: 162-168. 10.1067\/mcp.2002.121373.","journal-title":"Clin Pharmacol Ther"},{"key":"800_CR36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/0006-2952(92)90500-I","volume":"43","author":"CR Barnett","year":"1992","unstructured":"Barnett CR, Wilson J, Wolf CR, Flatt PR, Ioannides C: Hyperinsulinaemia causes a preferential increase in hepatic P4501A2 activity. Biochem Pharmacol. 1992, 43: 1255-1261. 10.1016\/0006-2952(92)90500-I.","journal-title":"Biochem Pharmacol"},{"key":"800_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0926-6917(95)90059-4","volume":"293","author":"A Irizar","year":"1995","unstructured":"Irizar A, Barnett CR, Flatt PR, Ioannides C: Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rat. Eur J Pharmacol. 1995, 293: 385-393. 10.1016\/0926-6917(95)90059-4.","journal-title":"Eur J Pharmacol"},{"key":"800_CR38","first-page":"45","volume":"111","author":"AG Smith","year":"2003","unstructured":"Smith AG, Davies R, Dalton TP, Miller ML, Judah D, Riley J, Gant T, Nebert DW: Intrinsic hepatic phenotype associated with the Cyp1a2 gene as shown by cDNA expression microarray analysis of the knockout mouse. EHP Toxicogenomics. 2003, 111: 45-51.","journal-title":"EHP Toxicogenomics"},{"key":"800_CR39","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1038\/sj.ijo.0801279","volume":"Suppl 2","author":"SM Haffner","year":"2000","unstructured":"Haffner SM: Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord. 2000, Suppl 2: S56-S58.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"800_CR40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0039-128X(96)00223-1","volume":"62","author":"SB Kristiansen","year":"1997","unstructured":"Kristiansen SB, Endoh A, Casson PR, Buster JE, Hornsby PJ: Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells. Steroids. 1997, 62: 258-265. 10.1016\/S0039-128X(96)00223-1.","journal-title":"Steroids"},{"key":"800_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.physiol.63.1.193","volume":"63","author":"DM Stocco","year":"2001","unstructured":"Stocco DM: StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol. 2001, 63: 193-213. 10.1146\/annurev.physiol.63.1.193.","journal-title":"Annu Rev Physiol"},{"key":"800_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2265.1974.tb03298.x","volume":"3","author":"DC Anderson","year":"1974","unstructured":"Anderson DC: Sex-hormone-binding globulin. Clin Endocrinol. 1974, 3: 69-96.","journal-title":"Clin Endocrinol"},{"key":"800_CR43","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1177\/00912709922008560","volume":"39","author":"BG Pollock","year":"1999","unstructured":"Pollock BG, Wylie M, Stack JA, Sorisio DA, Thompson DS, Kirshner MA, Folan MM, Condifer KA: Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women. J Clin Pharmacol. 1999, 39: 936-940. 10.1177\/00912709922008560.","journal-title":"J Clin Pharmacol"},{"key":"800_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/BF02285099","volume":"43","author":"JD Lane","year":"1992","unstructured":"Lane JD, Steege JF, Rupp SL, Kuhn CM: Menstrual cycle effects on caffeine elimination in the human female. Eur J Clin Pharmacol. 1992, 43: 543-546.","journal-title":"Eur J Clin Pharmacol"},{"key":"800_CR45","first-page":"19","volume":"83","author":"MS Marsh","year":"1994","unstructured":"Marsh MS, Crook D, Whitcroft SI, Worthington M, Whitehead MI, Stevenson JC: Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins. Obstet Gynecol. 1994, 83: 19-23.","journal-title":"Obstet Gynecol"},{"key":"800_CR46","first-page":"1","volume":"60","author":"H Higa","year":"1990","unstructured":"Higa H: Effects of catecholestrogen and catecholestrogen 2-monomethyl ether on serum lipids and lipoproteins in rats [in Japanese]. Igaku Kenkyu. 1990, 60: 1-17.","journal-title":"Igaku Kenkyu"},{"key":"800_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/01635589709514539","volume":"27","author":"PJ Goodwin","year":"1997","unstructured":"Goodwin PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A, Redwood S, Hood N, DelGiudice ME, Sidlofsky S, McCready D, Wilkinson R, Mahoney L, Connelly P, Page DL: Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer. 1997, 27: 284-292.","journal-title":"Nutr Cancer"},{"key":"800_CR48","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00008469-200106000-00013","volume":"10","author":"J Manjer","year":"2001","unstructured":"Manjer J, Malina J, Berglund G, Bondeson L, Garne JP, Janzon L: Breast cancer incidence in ex-smokers in relation to body mass index, weight gain and blood lipid levels. Eur J Cancer Prev. 2001, 10: 281-287. 10.1097\/00008469-200106000-00013.","journal-title":"Eur J Cancer Prev"},{"key":"800_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1677\/joe.0.1730103","volume":"173","author":"J Ragoobir","year":"2002","unstructured":"Ragoobir J, Abayasekara DR, Bruckdorfer KR, Michael AE: Stimulation of progesterone production in human granulosa-lutein cells by lipoproteins: evidence for cholesterol-independent actions of high-density lipoproteins. J Endocrinol. 2002, 173: 103-111.","journal-title":"J Endocrinol"},{"key":"800_CR50","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0002-9378(90)90420-C","volume":"162","author":"JA Baron","year":"1990","unstructured":"Baron JA, La Vecchia C, Levi F: The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol. 1990, 162: 502-514.","journal-title":"Am J Obstet Gynecol"},{"key":"800_CR51","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/jnci\/92.20.1666","volume":"92","author":"D Wartenberg","year":"2000","unstructured":"Wartenberg D, Calle EE, Thun MJ, Heath CW, Lally C, Woodruff T: Passive smoking exposure and female breast cancer mortality. J Natl Cancer Inst. 2000, 92: 1666-1673. 10.1093\/jnci\/92.20.1666.","journal-title":"J Natl Cancer Inst"},{"key":"800_CR52","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/jnci\/90.10.761","volume":"90","author":"JS Brunet","year":"1998","unstructured":"Brunet JS, Ghadirian P, Rebbeck T, Lerman C, Garber JE, Tonin PA, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT, Narod SA: Effect of smoking on breast cancer in carriers of mutant BRCA1 and BRCA2 genes. J Natl Cancer Inst. 1998, 90: 761-765. 10.1093\/jnci\/90.10.761.","journal-title":"J Natl Cancer Inst"},{"key":"800_CR53","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0959-8049(97)10167-8","volume":"34","author":"S Cold","year":"1998","unstructured":"Cold S, Hansen S, Overvad K, Rose C: A woman's build and the risk of breast cancer. Eur J Cancer. 1998, 34: 1163-1174. 10.1016\/S0959-8049(97)10167-8.","journal-title":"Eur J Cancer"},{"key":"800_CR54","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00001648-200011000-00004","volume":"11","author":"P Muti","year":"2000","unstructured":"Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Sch\u00fcnemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M, Berrino F: Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16\u03b1-hydroxyestrone ratio in pre- and postmenopausal women. Epidemiology. 2000, 11: 635-640. 10.1097\/00001648-200011000-00004.","journal-title":"Epidemiology"},{"key":"800_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00008571-199702000-00002","volume":"7","author":"L Le Marchand","year":"1997","unstructured":"Le Marchand L, Franke AA, Custer L, Wilkens LR, Cooney RV: Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics. 1997, 7: 11-19.","journal-title":"Pharmacogenetics"},{"key":"800_CR56","first-page":"529","volume":"24","author":"L Chen","year":"1996","unstructured":"Chen L, Bondoc FY, Lee MJ, Hussin AH, Thomas PE, Yang CS: Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats. Drug Metab Dispos. 1996, 24: 529-533.","journal-title":"Drug Metab Dispos"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr798\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:29:15Z","timestamp":1714062555000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,7]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2004,8]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1186\/bcr798","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,7]]},"assertion":[{"value":"26 August 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2004","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"R352"}}